Epothilones: Better or more of the same? Journal Article
| Authors: | Sabbatini, P.; Spriggs, D. R. |
| Article Title: | Epothilones: Better or more of the same? |
| Keywords: | protein expression; treatment response; clinical trial; drug activity; neutropenia; doxorubicin; advanced cancer; diarrhea; drug efficacy; monotherapy; antineoplastic agents; clinical trials as topic; capecitabine; paclitaxel; topotecan; antineoplastic agent; endometrium cancer; neoplasm; neoplasms; cell proliferation; biological marker; animal; animals; metastasis; progression free survival; ovary cancer; breast cancer; neuropathy; cell line; editorial; cancer therapy; docetaxel; asthenia; correlation analysis; taxane derivative; mammalian target of rapamycin inhibitor; anthracycline; microtubule; alopecia; gynecologic cancer; multidrug resistance; ixabepilone; epothilones; 9,10 didehydroepothilone d; epothilone b; epothilone d; epothilone derivative; tubulin modulator; tubulin modulators; tau protein |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 27 |
| Issue: | 19 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2009-07-01 |
| Start Page: | 3079 |
| End Page: | 3081 |
| Language: | English |
| DOI: | 10.1200/jco.2008.21.6481 |
| PUBMED: | 19451426 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 3" - "Export Date: 30 November 2010" - "CODEN: JCOND" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
